Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker
for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging …

Liquid biopsies are emerging as an alternative source for pediatric cancer biomarkers with
potential applications during all stages of patient care, from diagnosis to long-term follow-up …

Background Early diagnosis of hepatocellular carcinoma (HCC) is essential towards the
improvement of prognosis and patient survival. Circulating markers such as α-fetoprotein …

Background Alpha-fetoprotein (AFP) is a biomarker used in clinical management of
hepatocellular carcinoma (HCC), however, approximately 40% of HCC patients do not …

Hepatocellular carcinoma (HCC) is the primary malignancy of hepatocytes and the second
most common cause of cancer-related mortality across the globe. Despite significant …

Background Screening of early hepatocellular carcinoma (HCC) diagnosis is the greatest
challenge for hepatologists. Alpha-fetoprotein (AFP) is the most common non-invasive …

Background Serum AFP levels are typically elevated in less than 50% of hepatocellular
cancer (HCC) patients. Gamma-glutamyl transpeptidase (GGT) levels have been suggested …

Purpose Non-invasive biomarkers for diagnosing and prognosing hepatocellular carcinoma
(HCC) are urgently needed. Cirrhosis is present in 80–90% of HCC patients. Cirrhosis is …

Introduction Hepatocellular carcinoma is associated with several chronic inflammatory
conditions. It is increasingly understood that the inflammation may be part of the …

Objective: To propose a new decision algorithm combining biomarkers measured in a tumor
biopsy with clinical variables, to predict recurrence after liver transplantation (LT) …